rs27362
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001962.3(EFNA5):c.126-74544C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0814 in 152,120 control chromosomes in the GnomAD database, including 1,081 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.081 ( 1081 hom., cov: 32)
Consequence
EFNA5
NM_001962.3 intron
NM_001962.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.539
Publications
2 publications found
Genes affected
EFNA5 (HGNC:3225): (ephrin A5) Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFNA5 | NM_001962.3 | c.126-74544C>T | intron_variant | Intron 1 of 4 | ENST00000333274.11 | NP_001953.1 | ||
| EFNA5 | XM_011543250.4 | c.-8080C>T | 5_prime_UTR_variant | Exon 1 of 5 | XP_011541552.1 | |||
| EFNA5 | NM_001410773.1 | c.126-74544C>T | intron_variant | Intron 1 of 3 | NP_001397702.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EFNA5 | ENST00000333274.11 | c.126-74544C>T | intron_variant | Intron 1 of 4 | 1 | NM_001962.3 | ENSP00000328777.6 | |||
| EFNA5 | ENST00000504941.1 | n.398-74544C>T | intron_variant | Intron 1 of 1 | 1 | |||||
| EFNA5 | ENST00000509503.1 | c.126-74544C>T | intron_variant | Intron 1 of 3 | 5 | ENSP00000426989.1 | ||||
| EFNA5 | ENST00000505499.1 | n.56+4083C>T | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0813 AC: 12354AN: 152002Hom.: 1078 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
12354
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0814 AC: 12383AN: 152120Hom.: 1081 Cov.: 32 AF XY: 0.0859 AC XY: 6384AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
12383
AN:
152120
Hom.:
Cov.:
32
AF XY:
AC XY:
6384
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
7931
AN:
41470
American (AMR)
AF:
AC:
2090
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
59
AN:
3470
East Asian (EAS)
AF:
AC:
930
AN:
5182
South Asian (SAS)
AF:
AC:
222
AN:
4810
European-Finnish (FIN)
AF:
AC:
683
AN:
10586
Middle Eastern (MID)
AF:
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
AC:
314
AN:
68014
Other (OTH)
AF:
AC:
146
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
503
1006
1510
2013
2516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
411
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.